Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Sutro Biopharma, Inc. (S09.F)

Compare
1.6800
-0.0600
(-3.45%)
At close: February 21 at 3:29:01 PM GMT+1

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
ALBINI EDWARD C Chief Financial Officer Conversion of Exercise of derivative security Mar 5, 2024 106,743
BORGMAN ANNE ELIZABETH Officer Conversion of Exercise of derivative security Feb 29, 2024 24,374
CHUNG JANE President Conversion of Exercise of derivative security Nov 29, 2024 70,342
FITZPATRICK LINDA A. Officer Conversion of Exercise of derivative security Mar 5, 2024 83,335
GERBER HANS-PETER PH.D. Officer Conversion of Exercise of derivative security Sep 18, 2024 24,120
NEWELL WILLIAM J Chief Executive Officer Conversion of Exercise of derivative security Mar 5, 2024 336,728
PETREE DANIEL HUNTER Director Stock Gift Jun 27, 2023 22,457
SHTYLLA BRUNILDA Officer Sale Aug 28, 2023 0
SRINIVASAN VENKATESH Chief Technology Officer Conversion of Exercise of derivative security May 1, 2024 31,730
VASQUEZ NICKI J Officer Sale Jan 29, 2024 14,279

Related Tickers